Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
AlzeCure Publishes its Year-End Report for January – December 2025
April 30, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 30, 2026
Pain Project ACD440 Granted Orphan Drug Status in the EU
April 29, 2026
AlzeCure Abstract on NeuroRestore ACD856 accepted at the Alzheimer’s conference AP/PD 2026
February 3, 2026
←
Previous Page
1
2
3